543 related articles for article (PubMed ID: 21262918)
1. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.
Benjamin JL; Hedin CR; Koutsoumpas A; Ng SC; McCarthy NE; Hart AL; Kamm MA; Sanderson JD; Knight SC; Forbes A; Stagg AJ; Whelan K; Lindsay JO
Gut; 2011 Jul; 60(7):923-9. PubMed ID: 21262918
[TBL] [Abstract][Full Text] [Related]
2. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease.
Lindsay JO; Whelan K; Stagg AJ; Gobin P; Al-Hassi HO; Rayment N; Kamm MA; Knight SC; Forbes A
Gut; 2006 Mar; 55(3):348-55. PubMed ID: 16162680
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.
Steed H; Macfarlane GT; Blackett KL; Bahrami B; Reynolds N; Walsh SV; Cummings JH; Macfarlane S
Aliment Pharmacol Ther; 2010 Oct; 32(7):872-83. PubMed ID: 20735782
[TBL] [Abstract][Full Text] [Related]
4. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats.
Koleva PT; Valcheva RS; Sun X; Gänzle MG; Dieleman LA
Br J Nutr; 2012 Nov; 108(9):1633-43. PubMed ID: 22243836
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial.
Yen CH; Kuo YW; Tseng YH; Lee MC; Chen HL
Nutrition; 2011 Mar; 27(3):323-8. PubMed ID: 20579847
[TBL] [Abstract][Full Text] [Related]
6. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial.
Scholtens PA; Alles MS; Bindels JG; van der Linde EG; Tolboom JJ; Knol J
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):553-9. PubMed ID: 16707980
[TBL] [Abstract][Full Text] [Related]
7. Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life.
Wierdsma NJ; van Bodegraven AA; Uitdehaag BM; Arjaans W; Savelkoul PH; Kruizenga HM; van Bokhorst-de van der Schueren MA
Scand J Gastroenterol; 2009; 44(7):804-12. PubMed ID: 19347770
[TBL] [Abstract][Full Text] [Related]
8. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment.
Ladirat SE; Schoterman MH; Rahaoui H; Mars M; Schuren FH; Gruppen H; Nauta A; Schols HA
Br J Nutr; 2014 Aug; 112(4):536-46. PubMed ID: 24925303
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin-12 antibody for active Crohn's disease.
Mannon PJ; Fuss IJ; Mayer L; Elson CO; Sandborn WJ; Present D; Dolin B; Goodman N; Groden C; Hornung RL; Quezado M; Yang Z; Neurath MF; Salfeld J; Veldman GM; Schwertschlag U; Strober W;
N Engl J Med; 2004 Nov; 351(20):2069-79. PubMed ID: 15537905
[TBL] [Abstract][Full Text] [Related]
10. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
[TBL] [Abstract][Full Text] [Related]
11. Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota.
Mitsou EK; Turunen K; Anapliotis P; Zisi D; Spiliotis V; Kyriacou A
Int J Food Microbiol; 2009 Oct; 135(2):112-7. PubMed ID: 19735957
[TBL] [Abstract][Full Text] [Related]
12. Sargramostim for active Crohn's disease.
Korzenik JR; Dieckgraefe BK; Valentine JF; Hausman DF; Gilbert MJ;
N Engl J Med; 2005 May; 352(21):2193-201. PubMed ID: 15917384
[TBL] [Abstract][Full Text] [Related]
13. Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.
García-Peris P; Velasco C; Lozano MA; Moreno Y; Paron L; de la Cuerda C; Bretón I; Camblor M; García-Hernández J; Guarner F; Hernández M
Nutr Hosp; 2012; 27(6):1908-15. PubMed ID: 23588438
[TBL] [Abstract][Full Text] [Related]
14. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease.
Ng SC; Benjamin JL; McCarthy NE; Hedin CR; Koutsoumpas A; Plamondon S; Price CL; Hart AL; Kamm MA; Forbes A; Knight SC; Lindsay JO; Whelan K; Stagg AJ
Inflamm Bowel Dis; 2011 Oct; 17(10):2027-37. PubMed ID: 21910165
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
[TBL] [Abstract][Full Text] [Related]
17. Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial.
Majid HA; Cole J; Emery PW; Whelan K
Clin Nutr; 2014 Dec; 33(6):966-72. PubMed ID: 24290345
[TBL] [Abstract][Full Text] [Related]
18. Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial.
Prantera C; Rizzi M; Cottone M; Casa A; Annese V; Sturniolo GC; Marconi S; Lochs H
Dig Liver Dis; 2011 Jun; 43(6):459-64. PubMed ID: 21215714
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.
Rutgeerts P; Van Assche G; Sandborn WJ; Wolf DC; Geboes K; Colombel JF; Reinisch W; ; Kumar A; Lazar A; Camez A; Lomax KG; Pollack PF; D'Haens G
Gastroenterology; 2012 May; 142(5):1102-1111.e2. PubMed ID: 22326435
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
